Hikma Pharmaceuticals PLC

OTC
HKMPF
paper.types.company
Rentabilité sur six mois: +4.09%
Rendement en dividendes: 3.03%

27.73 $

0 $ +0%
22.56 $
28.92 $

paper.min_max_per_year

Calendrier des promotions Hikma Pharmaceuticals PLC

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. It also offers its products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates in the United Kingdom, rest of Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, the United Kingdom.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

Paramètres de base

Industry
Pharmaceuticals
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Див.доход ао
3.05
Дивиденд ао
0.48
Сайт
lien
Tous les paramètres

Grade

Sous-estimation
Nom Signification Grade
P/S 1.7 8
P/BV 2.29 6
P/E 14.81 8
Efficacité
Nom Signification Grade
ROA 7.32 2
ROE 15.93 5
ROIC 0 0
Dividendes
Nom Signification Grade
Rendement en dividendes 3.03 7.58
DSI 1 10
Croissance moyenne du dividende 12.57 10
Devoir
Nom Signification Grade
Debt/EBITDA 1.8 7
Debt/Ratio 0.2544 10
Debt/Equity 1.21 8
Impulsion de croissance
Nom Signification Grade
Rentabilité Revenue, % 33.63 5
Rentabilité Ebitda, % 3.12 1
Rentabilité EPS, % -12.91 0
Plus de détails

paper.price.prices

Prix Common.min. Common.max. Changement paper.changes_in_industry paper.changes_in_index
common.calendar.number_days.1 27.73 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.7d 27.73 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.30d 27.73 $ 27.73 $ 27.73 $ 0 % 0 % 0 %
common.calendar.number_days.90d 26.2 $ 26.2 $ 27.73 $ 5.86 % 0 % 0 %
common.calendar.number_days.180d 26.64 $ 24.59 $ 28.92 $ 4.09 % 0 % 0 %
common.calendar.number_days.1y 25.96 $ 22.56 $ 28.92 $ 6.82 % 0 % 0 %
common.calendar.number_days.3y 14.86 $ 13.76 $ 28.92 $ 86.61 % 0 % 0 %
common.calendar.number_days.5y 13.76 $ 13.76 $ 129.18 $ 201.53 % 0 % 0 %
common.calendar.number_days.10y 12 $ 12 $ 129.18 $ 231.08 % 0 % 0 %
common.calendar.number_days.ytd 26.64 $ 24.59 $ 28.92 $ 4.09 % 0 % 0 %

Gestion d'entreprise

Superviseur Titre d'emploi Paiement Année de naissance
Mr. Mazen Samih Taleb Darwazah Executive Vice Chairman & President of MENA 2.3M 1958 (67 années)
Mr. Khalid Waleed Hosny Al Nabilsi Chief Financial Officer N/A 1972 (53 année)
Mr. Guy Featherstone Associate Director of Investor Relations N/A
Mr. Bassam Wael Rushdi Kanaan CFA, CPA Executive Vice President of Corporate Development and M&A N/A 1965 (60 années)
Mr. Hussein Omar Arkhagha Chief People Officer N/A
Ms. Susan Ringdal Executive Vice President of Strategic Planning & Global Affairs N/A
Mr. Samuel Park General Counsel N/A
Engineer Said Samih Taleb Darwazah Executive Chairman 2.8M 1957 (68 années)
Mr. Riad Ali Mishlawi CEO & Director 1.1M 1964 (61 année)
Patricia Bousfield Chief Information Officer N/A

Informations sur l'entreprise

Adresse: United Kingdom, London WS HR, 1 New Burlington Place - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.hikma.com